These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8659280)

  • 21. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures.
    Ruszat R; Seitz M; Wyler SF; Abe C; Rieken M; Reich O; Gasser TC; Bachmann A
    Eur Urol; 2008 Oct; 54(4):893-901. PubMed ID: 18486311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
    Dib PT; Trigo-Rocha F; Gomes CM; Srougi M
    Urol Int; 2008; 80(4):378-82. PubMed ID: 18587248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement--a prospective randomized study.
    Liedberg F; Adell L; Hagberg G; Palmqvist IB
    Scand J Urol Nephrol; 2003; 37(6):494-7. PubMed ID: 14675923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
    Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
    Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up.
    Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A
    Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A comparative study on the photoselective vaporization of the prostate and transurethral electrovaporization resection of prostate for the treatment of benign prostatic hyperplasia].
    Yang Y; Hong BF; Fu WJ; Xu Y; Chen YF; Zhang CE
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):951-3. PubMed ID: 17961377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
    Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
    Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of preoperative urodynamics to the prognosis of transurethral prostate resection for benign prostatic hyperplasia].
    Cheng W; Gao JP; Zhang ZY; Ge JP; Xue S
    Zhonghua Nan Ke Xue; 2005 Mar; 11(3):207-9. PubMed ID: 15804115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia.
    Tubaro A; Carter S; Hind A; Vicentini C; Miano L
    J Urol; 2001 Jul; 166(1):172-6. PubMed ID: 11435849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
    van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
    J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of the urinary status by self-administered questionnaires in men after radical prostatectomy-- comparison with the urination status of elderly women].
    Taoka R; Shimada O; Kitamura Y; Okazoe H; Taniguchi S; Tsunemori H; Wu X; Inui M; Sugimoto M; Kakehi Y
    Hinyokika Kiyo; 2008 Nov; 54(11):717-22. PubMed ID: 19068725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two-years follow-up of radiofrequency thermotherapy for urination disorders due to benign prostatic hyperplasia].
    Savoie PH; Lopez L; Simonin O; Loubat M; Bladou F; Serment G; Karsenty G
    Prog Urol; 2009 Jul; 19(7):501-6. PubMed ID: 19559382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
    Pfitzenmaier J; Gilfrich C; Pritsch M; Herrmann D; Buse S; Haferkamp A; Djakovic N; Pahernik S; Hohenfellner M
    BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of nocturia quality of life before and shortly after prostatectomy.
    Margel D; Lifshitz D; Brown N; Lask D; Livne PM; Tal R
    Urology; 2007 Sep; 70(3):493-7. PubMed ID: 17905104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.